BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34192414)

  • 1. Causes and prevention of kidney stones: separating myth from fact.
    Garbens A; Pearle MS
    BJU Int; 2021 Dec; 128(6):661-666. PubMed ID: 34192414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phyllanthus niruri (stone breaker) herbal therapy for kidney stones; a systematic review and meta-analysis of clinical efficacy, and Google Trends analysis of public interest.
    Dhawan S; Olweny EO
    Can J Urol; 2020 Apr; 27(2):10162-10166. PubMed ID: 32333735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can Phyllanthus niruri affect the efficacy of extracorporeal shock wave lithotripsy for renal stones? A randomized, prospective, long-term study.
    Micali S; Sighinolfi MC; Celia A; De Stefani S; Grande M; Cicero AF; Bianchi G
    J Urol; 2006 Sep; 176(3):1020-2. PubMed ID: 16890682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation.
    Koff SG; Paquette EL; Cullen J; Gancarczyk KK; Tucciarone PR; Schenkman NS
    Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phyllanthus niruri as a promising alternative treatment for nephrolithiasis.
    Boim MA; Heilberg IP; Schor N
    Int Braz J Urol; 2010; 36(6):657-64; discussion 664. PubMed ID: 21176271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytotherapy and Herbal Medicines for Kidney Stones.
    Emiliani E; Jara A; Kanashiro AK
    Curr Drug Targets; 2021; 22(1):22-30. PubMed ID: 32990535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of Dietary Approaches to Stop Hypertension-style diet with urinary risk factors of kidney stones formation in men with nephrolithiasis.
    Maddahi N; Aghamir SMK; Moddaresi SS; Mirzaei K; Alizadeh S; Yekaninejad MS
    Clin Nutr ESPEN; 2020 Oct; 39():173-179. PubMed ID: 32859313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Orthosiphon grandiflorus, Hibiscus sabdariffa and Phyllanthus amarus extracts on risk factors for urinary calcium oxalate stones in rats.
    Woottisin S; Hossain RZ; Yachantha C; Sriboonlue P; Ogawa Y; Saito S
    J Urol; 2011 Jan; 185(1):323-8. PubMed ID: 21075390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buyer Beware: Evidence-Based Evaluation of Dietary Supplements for Nephrolithiasis.
    Koo K; Aro T; Matlaga BR
    J Endourol; 2020 Jun; 34(6):702-707. PubMed ID: 31928071
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation.
    Freitas AM; Schor N; Boim MA
    BJU Int; 2002 Jun; 89(9):829-34. PubMed ID: 12010223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of an aqueous extract from Phyllantus niruri on calcium oxalate crystallization in vitro.
    Barros ME; Schor N; Boim MA
    Urol Res; 2003 Feb; 30(6):374-9. PubMed ID: 12599017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ayurvedic medicine and renal calculi.
    Kieley S; Dwivedi R; Monga M
    J Endourol; 2008 Aug; 22(8):1613-6. PubMed ID: 18620498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lemonade blocks kidney stone formation.
    Health News; 2006 Aug; 12(8):10-1. PubMed ID: 16913031
    [No Abstract]   [Full Text] [Related]  

  • 15. Kidney stones: an update on current pharmacological management and future directions.
    Xu H; Zisman AL; Coe FL; Worcester EM
    Expert Opin Pharmacother; 2013 Mar; 14(4):435-47. PubMed ID: 23438422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutrition and Kidney Stone Disease.
    Siener R
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34204863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkalinizing Agents: A Review of Prescription, Over-the-Counter, and Medical Food Supplements.
    Stern KL; Canvasser N; Borofsky M; Gleason VM; Kamphuis G; El Tayeb MM; Hsi R; Scotland KB
    J Endourol; 2020 Jan; 34(1):1-6. PubMed ID: 31333065
    [No Abstract]   [Full Text] [Related]  

  • 18. Phyllanthus niruri normalizes elevated urinary calcium levels in calcium stone forming (CSF) patients.
    Nishiura JL; Campos AH; Boim MA; Heilberg IP; Schor N
    Urol Res; 2004 Oct; 32(5):362-6. PubMed ID: 15221244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why is diagnosis, investigation, and improved management of kidney stone disease important? Non-pharmacological and pharmacological treatments for nephrolithiasis.
    D'Ambrosio V; Moochhala S; Unwin RJ; Ferraro PM
    Expert Rev Clin Pharmacol; 2022 Apr; 15(4):407-414. PubMed ID: 35612529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical management of urinary stone disease.
    Park S
    Expert Opin Pharmacother; 2007 Jun; 8(8):1117-25. PubMed ID: 17516875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.